181 related articles for article (PubMed ID: 15500552)
21. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
[TBL] [Abstract][Full Text] [Related]
22. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
[TBL] [Abstract][Full Text] [Related]
23. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
Chang LL; Cheng PN; Chen JS; Young KC
Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
[TBL] [Abstract][Full Text] [Related]
24. [Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection].
Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):363-70. PubMed ID: 12506240
[TBL] [Abstract][Full Text] [Related]
25. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis.
Mack M; Brühl H; Gruber R; Jaeger C; Cihak J; Eiter V; Plachý J; Stangassinger M; Uhlig K; Schattenkirchner M; Schlöndorff D
Arthritis Rheum; 1999 May; 42(5):981-8. PubMed ID: 10323454
[TBL] [Abstract][Full Text] [Related]
26. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
27. CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?
Ahlenstiel G; Woitas RP; Rockstroh J; Spengler U
J Antimicrob Chemother; 2004 Jun; 53(6):895-8. PubMed ID: 15128728
[TBL] [Abstract][Full Text] [Related]
28. Participation of RANTES and T-cell apoptosis in human renal allograft.
Racca A; Bailat A; García MI; Soutullo A; Gaite L; Malan Borel I
Scand J Immunol; 2005 Feb; 61(2):157-64. PubMed ID: 15683452
[TBL] [Abstract][Full Text] [Related]
29. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
Lin YL; Mettling C; Portalès P; Rouzier R; Clot J; Reynes J; Corbeau P
AIDS; 2008 Jan; 22(3):430-2. PubMed ID: 18195571
[TBL] [Abstract][Full Text] [Related]
30. Antiviral chemokines: intracellular life of recombinant C-C chemokine RANTES.
Owais M; Arya SK
J Hum Virol; 1999; 2(5):270-82. PubMed ID: 10551733
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
32. Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implication in Q fever.
Meghari S; Desnues B; Capo C; Grau GE; Raoult D; Mege JL
Eur Cytokine Netw; 2006 Dec; 17(4):253-9. PubMed ID: 17353158
[TBL] [Abstract][Full Text] [Related]
33. The hepatitis C envelope 2 protein inhibits LFA-1-transduced protein kinase C signaling for T-lymphocyte migration.
Volkov Y; Long A; Freeley M; Golden-Mason L; O'Farrelly C; Murphy A; Kelleher D
Gastroenterology; 2006 Feb; 130(2):482-92. PubMed ID: 16472601
[TBL] [Abstract][Full Text] [Related]
34. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
35. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5.
Lim JK; Burns JM; Lu W; DeVico AL
J Leukoc Biol; 2005 Aug; 78(2):442-52. PubMed ID: 15923218
[TBL] [Abstract][Full Text] [Related]
36. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
[TBL] [Abstract][Full Text] [Related]
37. Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation.
Wang J; Holmes TH; Cheung R; Greenberg HB; He XS
J Infect Dis; 2004 Sep; 190(5):989-97. PubMed ID: 15295707
[TBL] [Abstract][Full Text] [Related]
38. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production.
Blaak H; Ran LJ; Rientsma R; Schuitemaker H
Virology; 2000 Feb; 267(2):237-46. PubMed ID: 10662619
[TBL] [Abstract][Full Text] [Related]
40. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
